Mylan’s long-awaited rival for Teva’s blockbuster multiple sclerosis drug Copaxone has been approved in the US, putting a large chunk of the Israeli firm’s revenues at risk. The timing could ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of multiple sclerosis drugs including Teva's Copaxone. The health ...
It’s not known whether Copaxone (glatiramer acetate) is safe to use while pregnant or breastfeeding. Certain factors, including the risks of fetal harm, may determine whether you should use the ...
Initially intended to mimic multiple sclerosis (MS) in animal models, these compounds unexpectedly led to a breakthrough drug, Copaxone, used worldwide to treat MS. Decades later, this versatile ...
The Food and Drug Administration is adding a boxed warning about the risk of an allergic reaction for Teva‘s (TEVA) Copaxone and Sandoz’s ...
The analyst firm said the company looked likely to gain final clearance to market its generic version of Teva's multiple sclerosis drug Copaxone (glatiramer) in the near future. Copaxone is a ...
Marketed under the names Copaxone and Glatopa, glatiramer acetate is indicated for the treatment of relapsing forms of multiple sclerosis (MS). Worldwide, there have been 82 cases of anaphylaxis ...
Teva markets the drug under the name Copaxone, while a generic version of the drug, Glatopa, is sold by Sandoz (SDZ.S), opens new tab. The companies did not immediately respond to requests for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback